FI753333A - - Google Patents

Info

Publication number
FI753333A
FI753333A FI753333A FI753333A FI753333A FI 753333 A FI753333 A FI 753333A FI 753333 A FI753333 A FI 753333A FI 753333 A FI753333 A FI 753333A FI 753333 A FI753333 A FI 753333A
Authority
FI
Finland
Application number
FI753333A
Other languages
Finnish (fi)
Other versions
FI66004B (fi
FI66004C (fi
Inventor
Hans-Bodo Koenig
Karl Georg Metzger
Michael Preiss
Wilfried Schroeck
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742456307 external-priority patent/DE2456307A1/de
Priority claimed from DE19752512998 external-priority patent/DE2512998A1/de
Priority claimed from DE19752525541 external-priority patent/DE2525541C2/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI753333A publication Critical patent/FI753333A/fi
Publication of FI66004B publication Critical patent/FI66004B/fi
Application granted granted Critical
Publication of FI66004C publication Critical patent/FI66004C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI753333A 1974-11-28 1975-11-26 Foerfarande foer framstaellning av beta-laktamantibiotika anvaendbara saosom laekemedel FI66004C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE19742456307 DE2456307A1 (de) 1974-11-28 1974-11-28 Beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2456307 1974-11-28
DE2512998 1975-03-25
DE19752512998 DE2512998A1 (de) 1975-03-25 1975-03-25 Beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19752525541 DE2525541C2 (de) 1975-06-07 1975-06-07 β-Lactam-Antibiotica, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2525541 1975-06-07

Publications (3)

Publication Number Publication Date
FI753333A true FI753333A (xx) 1976-05-29
FI66004B FI66004B (fi) 1984-04-30
FI66004C FI66004C (fi) 1984-08-10

Family

ID=27186174

Family Applications (1)

Application Number Title Priority Date Filing Date
FI753333A FI66004C (fi) 1974-11-28 1975-11-26 Foerfarande foer framstaellning av beta-laktamantibiotika anvaendbara saosom laekemedel

Country Status (22)

Country Link
US (1) US4147693A (xx)
JP (2) JPS6043332B2 (xx)
AR (1) AR210103A1 (xx)
AT (1) AT342196B (xx)
AU (1) AU499337B2 (xx)
CA (1) CA1064020A (xx)
CH (1) CH623326A5 (xx)
DD (1) DD124736A5 (xx)
DK (1) DK535675A (xx)
ES (1) ES443008A1 (xx)
FI (1) FI66004C (xx)
FR (1) FR2292471A1 (xx)
GB (1) GB1486349A (xx)
HK (1) HK19678A (xx)
IE (1) IE43813B1 (xx)
IL (1) IL48538A (xx)
LU (1) LU73873A1 (xx)
NL (1) NL7513746A (xx)
NO (1) NO753818L (xx)
NZ (1) NZ179347A (xx)
RO (1) RO68146A (xx)
SE (1) SE434513B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061861A (en) * 1976-06-21 1977-12-06 Eli Lilly And Company 7-[α-(2,3-DIHYDRO-2-OXO-1H-benzimidazol-1-ylcarbonyl-amino)arylacetamido]cephalosporins
JPS5326143A (en) * 1976-08-24 1978-03-10 Oki Electric Ind Co Ltd Coupling method for op tical fiber
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
GB1584400A (en) * 1976-12-24 1981-02-11 Bayer Ag (2-oxo-imidazoliden-1-yl(carbonylamino)-acetamido-cephalosporins and penicillins
DE2732283A1 (de) * 1977-07-16 1979-01-25 Bayer Ag Beta-lactam-verbindungen
JPS5616489A (en) * 1979-07-20 1981-02-17 Ajinomoto Co Inc Imidazolecarboxylic acid derivative
US4386199A (en) * 1980-01-03 1983-05-31 E. R. Squibb & Sons, Inc. Cephalosporins having an imino substituted piperazindioncarbonylamino acyl sidechain
US4436904A (en) * 1981-02-14 1984-03-13 Kanto Ishi Pharmaceutical Co., Ltd. Cephalosporins
GB8318846D0 (en) * 1983-07-12 1983-08-10 Fujisawa Pharmaceutical Co Prophylactic/therapeutic agent against fish diseases
CN103360321B (zh) * 2012-04-05 2016-09-21 北京勤邦生物技术有限公司 呋喃妥因代谢物半抗原及其制备方法和应用
CN111995663B (zh) * 2020-09-02 2023-07-28 重庆大学 一种含有N-氨基咪唑烷-2-酮结构的Ang-（1-7）多肽类似物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH562249A5 (xx) * 1970-05-25 1975-05-30 Bayer Ag
US3939149A (en) * 1970-05-25 1976-02-17 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
US3974140A (en) * 1970-05-25 1976-08-10 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
CH571524A5 (xx) * 1970-05-25 1976-01-15 Bayer Ag
US3980792A (en) * 1970-05-25 1976-09-14 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
US3732332A (en) * 1970-10-16 1973-05-08 Allied Chem Production of low molecular weight polyanhydrides and epoxy compositions derived therefrom
NL175419C (nl) * 1971-10-23 1984-11-01 Bayer Ag Werkwijze ter bereiding of vervaardiging van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van antibiotisch werkzame alfa-gesubstitueerde 6-(alfa-(3-acylureido)acetylamino) penicillanzuurderivaten.
BE790441A (fr) * 1971-10-23 1973-04-24 Bayer Ag Nouvelles penicillines, leur procede de preparation et medicament les contenant
US3983105A (en) * 1971-10-23 1976-09-28 Bayer Aktiengesellschaft Penicillins
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US3972870A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3974141A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US3978056A (en) * 1971-10-23 1976-08-31 Bayer Aktiengesellschaft Penicillins
DE2354219A1 (de) * 1973-10-30 1975-05-07 Bayer Ag Beta-lactam-antibiotica, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
CH623326A5 (xx) 1981-05-29
LU73873A1 (xx) 1976-09-06
FR2292471B1 (xx) 1981-12-31
DK535675A (da) 1976-05-29
JPS6043332B2 (ja) 1985-09-27
JPS6114151B2 (xx) 1986-04-17
FI66004B (fi) 1984-04-30
NZ179347A (en) 1978-04-28
NL7513746A (nl) 1976-06-01
RO68146A (ro) 1980-04-15
AR210103A1 (es) 1977-06-30
IE43813L (en) 1976-05-28
AT342196B (de) 1978-03-28
AU499337B2 (en) 1979-04-12
JPS5182286A (en) 1976-07-19
IL48538A0 (en) 1976-01-30
US4147693A (en) 1979-04-03
IE43813B1 (en) 1981-06-03
FR2292471A1 (fr) 1976-06-25
SE7513378L (sv) 1976-05-31
JPS5176438A (xx) 1976-07-02
IL48538A (en) 1979-07-25
GB1486349A (en) 1977-09-21
HK19678A (en) 1978-04-20
SE434513B (sv) 1984-07-30
DD124736A5 (xx) 1977-03-09
FI66004C (fi) 1984-08-10
ATA907275A (de) 1977-07-15
AU8708575A (en) 1977-06-02
ES443008A1 (es) 1977-05-01
CA1064020A (en) 1979-10-09
NO753818L (xx) 1976-05-31

Similar Documents

Publication Publication Date Title
FR2292471B1 (xx)
FR2277381B1 (xx)
FR2276932B3 (xx)
FR2268955A1 (xx)
FR2285125B1 (xx)
FR2270680A1 (xx)
AU495920B2 (xx)
HU170659B (xx)
FI740151A0 (xx)
CS172678B1 (xx)
AU7099174A (xx)
JPS50100858U (xx)
AU7138274A (xx)
BG21285A1 (xx)
BG21632A1 (xx)
BG20864A1 (xx)
BG26152A1 (xx)
BG20987A1 (xx)
BG20863A1 (xx)
BG20853A1 (xx)
BG21272A1 (xx)
BG21353A1 (xx)
BG20738A1 (xx)
BG21503A1 (xx)
BG20729A1 (xx)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BAYER AKTIENGESELLSCHAFT